Moore Matthew Richard
SEC CIK 1840191 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | See Remarks | 145.5K | — | $105.0K | 8 | 2022-03-03 | 2024-05-02 |
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
Moore Matthew Richard made no open-market trades at ARQT in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-03 | 2024-05-02 | ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | SVP, Chief Business Off | S - Sale | $8.74 | -4,681 | 145.5K | -3% | -$40.9K | |
| 2024-05-03 | 2024-05-01 | ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | SVP, Chief Business Off | A - Grant | $0.00 | +4,166 | 150.2K | +3% | $0 | |
| 2024-03-06 | 2024-03-04 | ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | SVP, Chief Business Off | S - Sale | $11.12 | -3,468 | 146.0K | -2% | -$38.6K | |
| DM | 2024-02-15 | 2024-02-13 | ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | SVP, Chief Business Off | A - Grant | — | +94.9K | 145.3K | +188% | — |
| D | 2024-01-17 | 2024-01-12 | ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | SVP, Chief Business Off | A - Grant | $0.00 | +28.0K | 54.6K | +105% | $0 |
| D | 2023-03-06 | 2023-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | See Remarks | A - Grant | $0.00 | +14.9K | 26.6K | +127% | $0 |
| DM | 2023-03-06 | 2023-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | See Remarks | S - Sale | $15.83 | -1,610 | 11.7K | -12% | -$25.5K |
| D | 2022-03-07 | 2022-03-03 | ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | SVP, Chief Business Off | A - Grant | $0.00 | +13.3K | 13.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations